Related references
Note: Only part of the references are listed.Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities
Mike M. Nguyen et al.
CANCER PREVENTION RESEARCH (2012)
Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor-Negative Breast Cancer
Katherine D. Crew et al.
CANCER PREVENTION RESEARCH (2012)
Effect of 2-Month Controlled Green Tea Intervention on Lipoprotein Cholesterol, Glucose, and Hormone Levels in Healthy Postmenopausal Women
Anna H. Wu et al.
CANCER PREVENTION RESEARCH (2012)
cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes
Kanwal P. Raghav et al.
CLINICAL CANCER RESEARCH (2012)
Green tea consumption and breast cancer risk or recurrence: a meta-analysis
Adeyemi A. Ogunleye et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2
Kathleen E. Malone et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors
N. R. Stendell-Hollis et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2010)
Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro
Jerry McLarty et al.
CANCER PREVENTION RESEARCH (2009)
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Chung S. Yang et al.
NATURE REVIEWS CANCER (2009)
Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats
Vadivel Senthil Kumaran et al.
EXPERIMENTAL GERONTOLOGY (2008)
Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity
Hyun-Seuk Moon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis
Bao-He Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies
Can-Lan Sun et al.
CARCINOGENESIS (2006)
Relationship between urinary 15-F2t isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk
P Rossner et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex
SK Rodriguez et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The green tea catechins, (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells
RLH Bigelow et al.
ONCOGENE (2006)
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer
SM Swain et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity
V Stearns et al.
CLINICAL CANCER RESEARCH (2004)
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay:: determination of cyclo oxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer
LJ Murphey et al.
ANALYTICAL BIOCHEMISTRY (2004)
Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea
J Liao et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E
PY Chang et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2003)
Sequential designs for phase I clinical trials with late-onset toxicities
YK Cheung et al.
BIOMETRICS (2000)
Share Paper
